Assessment Of Disease Pathology And Key Therapeutic Targets In Severe Asthma

This study has been terminated.
(The study was truncated due to the long period of enrollment and the collection of a sufficient amount of data that allowed the scientific objectives to be met)
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT00327197
First received: May 17, 2006
Last updated: December 19, 2012
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2011
  Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)